Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets
Go back to Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 60.97 -5.87 (8.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.84 | 52 Week High | $19.98 | |||
| Open | $67.08 | 52 Week Low | $10.52 | |||
| Day High | $68.33 | P/E | N/A | |||
| Day Low | $59.44 | EPS | $-1.45 | |||
| Volume | 3,292,556 | |||||
